AIM
EW icon

Anchor Investment Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$975K Sell
12,461
-29,279
-70% -$2.29M 0.09% 192
2025
Q1
$3.03M Buy
41,740
+393
+1% +$28.5K 0.28% 95
2024
Q4
$3.06M Buy
41,347
+4,623
+13% +$342K 0.29% 96
2024
Q3
$2.42M Sell
36,724
-1,311
-3% -$86.5K 0.23% 110
2024
Q2
$3.51M Sell
38,035
-800
-2% -$73.9K 0.36% 72
2024
Q1
$3.71M Buy
38,835
+649
+2% +$62K 0.39% 69
2023
Q4
$2.91M Buy
38,186
+9,160
+32% +$698K 0.33% 85
2023
Q3
$2.01M Buy
29,026
+191
+0.7% +$13.2K 0.26% 99
2023
Q2
$2.72M Sell
28,835
-3,009
-9% -$284K 0.35% 76
2023
Q1
$2.63M Buy
31,844
+455
+1% +$37.6K 0.36% 76
2022
Q4
$2.34M Buy
31,389
+1,179
+4% +$88K 0.34% 84
2022
Q3
$2.5M Sell
30,210
-1,302
-4% -$108K 0.39% 70
2022
Q2
$3M Buy
31,512
+8
+0% +$761 0.43% 62
2022
Q1
$3.71M Buy
31,504
+453
+1% +$53.3K 0.47% 60
2021
Q4
$4.02M Buy
31,051
+82
+0.3% +$10.6K 0.5% 57
2021
Q3
$3.51M Sell
30,969
-752
-2% -$85.1K 0.49% 60
2021
Q2
$3.29M Sell
31,721
-590
-2% -$61.1K 0.45% 67
2021
Q1
$2.7M Buy
32,311
+5,407
+20% +$452K 0.41% 70
2020
Q4
$2.45M Buy
26,904
+2,484
+10% +$227K 0.44% 70
2020
Q3
$1.95M Buy
24,420
+1,492
+7% +$119K 0.4% 73
2020
Q2
$1.58M Buy
22,928
+15,115
+193% +$1.04M 0.35% 83
2020
Q1
$1.47M Buy
7,813
+614
+9% +$116K 0.38% 76
2019
Q4
$1.68M Buy
7,199
+901
+14% +$210K 0.36% 84
2019
Q3
$1.38M Buy
6,298
+70
+1% +$15.4K 0.32% 93
2019
Q2
$1.15M Buy
6,228
+155
+3% +$28.6K 0.27% 103
2019
Q1
$1.16M Buy
6,073
+1,085
+22% +$208K 0.29% 97
2018
Q4
$764K Sell
4,988
-25
-0.5% -$3.83K 0.22% 120
2018
Q3
$873K Sell
5,013
-768
-13% -$134K 0.2% 131
2018
Q2
$842K Buy
5,781
+58
+1% +$8.44K 0.21% 128
2018
Q1
$798K Buy
5,723
+34
+0.6% +$4.74K 0.21% 127
2017
Q4
$641K Buy
5,689
+579
+11% +$65.3K 0.17% 140
2017
Q3
$559K Buy
5,110
+35
+0.7% +$3.83K 0.16% 143
2017
Q2
$600K Buy
5,075
+70
+1% +$8.28K 0.2% 115
2017
Q1
$471K Sell
5,005
-85
-2% -$8K 0.16% 137
2016
Q4
$477K Sell
5,090
-65
-1% -$6.09K 0.18% 128
2016
Q3
$621K Buy
5,155
+85
+2% +$10.2K 0.24% 105
2016
Q2
$506K Buy
5,070
+1,500
+42% +$150K 0.2% 116
2016
Q1
$315K Buy
+3,570
New +$315K 0.13% 165